Michael Shetzline

2020

In 2020, Michael Shetzline earned a total compensation of $1.9M as Chief Medical Officer, Senior Vice President and Head of Drug Development Development at Ironwood Pharmaceuticals.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$194,558
Salary$464,681
Stock Awards$1,121,001
Other$11,040
Total$1,891,310

Shetzline received $1.1M in stock awards, accounting for 59% of the total pay in 2020.

Shetzline also received $100K in bonus, $194.6K in non-equity incentive plan, $464.7K in salary and $11K in other compensation.

Rankings

In 2020, Michael Shetzline's compensation ranked 5,766th out of 13,090 executives tracked by ExecPay. In other words, Shetzline earned more than 56.0% of executives.

ClassificationRankingPercentile
All
5,766
out of 13,090
56th
Division
Manufacturing
2,375
out of 5,621
58th
Major group
Chemicals And Allied Products
950
out of 2,254
58th
Industry group
Drugs
822
out of 1,954
58th
Industry
Pharmaceutical Preparations
612
out of 1,459
58th

Pay ratio

Michael Shetzline's Pay$1,891,310
Median Employee's Pay$222,011
Pay Ratio

9

to 1

In 2020, the annual total compensation of Michael Shetzline was $1,891,310.

The annual total compensation of the median employee at Ironwood Pharmaceuticals was $222,011.

The ratio of Michael Shetzline's pay to the pay of median employee was therefore 9 to one.

Source: SEC filing on April 22, 2021.

Shetzline's colleagues

We found four more compensation records of executives who worked with Michael Shetzline at Ironwood Pharmaceuticals in 2020.

2020

Mark Mallon

Ironwood Pharmaceuticals

Chief Executive Officer

2020

Thomas McCourt

Ironwood Pharmaceuticals

Chief Executive Officer

2020

Gina Consylman

Ironwood Pharmaceuticals

Chief Financial Officer

2020

Jason Rickard

Ironwood Pharmaceuticals

Chief Operating Officer

News

You may also like